fluoxetine and phosphocreatine

fluoxetine has been researched along with phosphocreatine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohen, BM; Frederick, Bd; Hennen, J; Henry, ME; Kaufman, MJ; Renshaw, PF; Schmidt, ME; Stoddard, EP; Villafuerte, RA1
Fiedler, KK; Hellem, TL; Jeong, EK; Kondo, DG; Renshaw, PF; Shi, X; Sung, YH1
Achten, E; Cambron, M; Debruyne, J; Laureys, G; Reynders, T; Reyngoudt, H; Ribbens, A1
Cao, X; Chen, Y; Gao, T; Ou, CQ; Shen, X; Tan, S; Zang, W; Zhao, L1

Trials

4 trial(s) available for fluoxetine and phosphocreatine

ArticleYear
Selective serotonin reuptake inhibitor discontinuation syndrome is associated with a rostral anterior cingulate choline metabolite decrease: a proton magnetic resonance spectroscopic imaging study.
    Biological psychiatry, 2003, Sep-01, Volume: 54, Issue:5

    Topics: Adult; Brain Mapping; Choline; Depressive Disorder, Major; Female; Fluoxetine; Gyrus Cinguli; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Spectroscopy; Paroxetine; Phosphocreatine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Syndrome

2003
Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: a 31-phosphorus magnetic resonance spectroscopy study.
    Journal of affective disorders, 2011, Volume: 135, Issue:1-3

    Topics: Adolescent; Antidepressive Agents; Creatine; Depressive Disorder; Depressive Disorder, Major; Female; Fluoxetine; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Phosphocreatine; Phosphorus; Radionuclide Imaging; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

2011
Targeting phosphocreatine metabolism in relapsing-remitting multiple sclerosis: evaluation with brain MRI,
    Journal of neurology, 2018, Volume: 265, Issue:11

    Topics: Adult; Benzofurans; Brain; Double-Blind Method; Female; Fluoxetine; Gray Matter; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis, Relapsing-Remitting; Neuroprotective Agents; Organ Size; Phosphocreatine; Phosphorus Isotopes; Protons; Treatment Outcome; White Matter

2018
Intravenous administration of adenosine triphosphate and phosphocreatine combined with fluoxetine in major depressive disorder: protocol for a randomized, double-blind, placebo-controlled pilot study.
    Trials, 2019, Jan-09, Volume: 20, Issue:1

    Topics: Adenosine Triphosphate; Administration, Intravenous; Administration, Oral; Adolescent; Adult; Affect; Aged; Antidepressive Agents, Second-Generation; China; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Feasibility Studies; Female; Fluoxetine; Humans; Male; Middle Aged; Patient Health Questionnaire; Phosphocreatine; Pilot Projects; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Young Adult

2019